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Purpose. The purpose of this study was to compare the surgical and pathological variables which impact rate of re-excision
following breast conserving therapy (BCS) with or without concurrent additional margin excision (AM). Methods. The pathology
database was queried for all patients with DCIS from January 2004 to September 2008. Pathologic assessment included volume
of excision, subtype, size, distance from margin, grade, necrosis, multifocality, calciﬁcations, and ER/PR status. Results. 405 cases
were identiﬁed and 201 underwent BCS, 151-BCS-AM, and 53-mastectomy. Among the 201 BCS patients, 190 underwent re-
excision for close or involved margins. 129 of these were treated with BCS and 61 with BCS-AM (P<. 0001). The incidence of
residual DCIS in the re-excision specimens was 32% (n = 65) for BCS and 22% (n = 33) for BCS-AM (P<. 05). For both the
BCS and the BCS-AM cohorts, volume of tissue excised is inversely correlated to the rate of re-excision (P = .0284). Multifocality
(P = .0002) and ER status (P = .0382) were also signiﬁcant predictors for rate of re-excision and variation in surgical technique
was insigniﬁcant. Conclusions. The rate of positive margins, re-excision, and residual disease was signiﬁcantly higher in patients
with lower volume of excision. The performance of concurrent additional margin excision increases the eﬃcacy of BCS for DCIS.
1.Introduction
Ductal carcinoma in situ (DCIS) is a noninvasive cancer that
can be an obligate precursor of invasive ductal carcinoma
(IDC). Since the early 1990s, reported survival outcome
for DCIS is equivalent for breast conserving surgery (BCS)
versus mastectomy [1, 2] .B C Si sa no n c o p l a s t i cp r o c e d u r e ,
in that its goal is to remove all DCIS, including a circum-
ferential margin of noncarcinomatous tissue, commensurate
with preserving as much of the normal breast tissue and
appearance as possible.
While there is no consensus on a safe margin width in
breast conservation therapy, margins may be categorized as
positive if directly involved with cancer cells, as inadequate
if less than 1-2mm, and as negative if greater than 10mm
[3]. Multiple studies have shown thatipsilateral breasttumor
recurrence (IBTR) is associated with positive margins in
patients undergoing BCS [4–6]. Most recently, the Early
Breast Cancer Trialists’ Collaborative Group concluded that
the avoidance of four local recurrences would avoid breast
cancer-related death [7]. Thus, obtaining appropriate sur-
gical margins is of paramount importance in determining
long-term outcome.
Margin widthisalsooneof fourcriticalfactorsemployed
in the USC/Van Nuys prognostic index (UVPNI: age, lesion
size, margin width, and pathologic classiﬁcation) as a means
of appropriately stratifying patients with DCIS into three
separate treatment categories [8]. The UVNPI identiﬁes
those patients who may be treated without radiation and
those who may require mastectomy. While based on a
prospective non-randomization of patients, the UVPNI
provides guidelines to improve patients’ prognostic indices
with additional surgery that increases margin width. Margin
width is the only modiﬁable factor that may obviate the need
for radiation and reduce the risk of recurrence.
In an attempt to minimize the need for re-operation
and maintain anatomic accuracy, many surgeons now obtain
“additional margins” (BCS-AM) at the time of the initial2 International Journal of Surgical Oncology
surgery by shaving oﬀ a thin layer of tissue inside the surgical
cavity in one or all of the six dimensions. This shaved tissue
now serves as the “true” surgical margin. The eﬃcacy of
this approach in preventing re-excision and IBTR for IDC
and DCIS has been addressed in several studies [9–14]. The
added beneﬁt of re-excising additional tissue at the time
of initial surgery is the certainty of the location of the
additional tissue in relation to the index cancer. The purpose
of this paper is to compare BCS and BCS-AM procedures
with respect to rates of re-excision for DCIS based on our
institutional experience.
2.MaterialsandMethods
2.1. Case Accrual. Institutional Review Board approval was
obtained to query the Department of Pathology database
for all patients who underwent surgical management for
DCIS from January 2004 to September 2008, with all cases
reviewed by a single pathologist (B. Singh). The reports were
reviewed for demographic, surgical, and histopathologic
d a t a ,a sw e l la sr e o p e r a t i o n s .
A group of 405 patients were retrospectively identiﬁed
using patient records as having undergone surgical manage-
ment for DCIS at our institution. In 201 patients (50%),
standard BCS was performed (without removal of AM); in
151 patients (37%), BCS-AM was performed (Figure 1), the
remaining 53 patients (13%) underwent total mastectomy
(TM) as their initial surgical management.
Surgery was performed by thirteen surgeons in this
study. However, the ﬁrst four surgeons performed 86.6% of
the surgical procedures in the study. Since the other nine
surgeons did not perform a minimum of 30 surgeries, have a
minimum cell size of ﬁve for BCS and BCS-AM surgeries,
or perform a minimum of 10% of the surgeries in the
total sample, we did not compare their surgical techniques.
This maintains high statistical power levels of performed
ANOVA and chi-squared tests. The four surgeons abstracted
their patient charts for: (1) indications for surgery, including
a palpable mass, calciﬁcations, and mammographically or
MRI-detected lesions, (2) surgical technique: localization
wire or bracket and (3) indications for re-excision: mass,
residual calciﬁcations, or residual DCIS close to margins
(Table 1(b)). An individual patient may have more than one
indication for surgery.
In general, sentinel axillary node dissection with or
withoutformalaxillarynodaldissectionisnotperformedfor
cases of DCIS, as it is presumed to be localized disease.
2.2. Surgical Technique
2.2.1. Surgeon A. For non-palpable lesions, a modiﬁed
Kopans hook wire localizes the lesion in 2 views (including
after a sonographic localization) and is performed in the
Department of Breast Imaging by the radiologist. In the
resection of superﬁcial lesions, an ellipse of skin is included,
and, for deep lesions close to the chest wall, fascia is
included.Intraoperatively,atleasta1cmrimofnormaltissue
in all directions is taken. Electrocauterization and sharp
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Figure 1: (a) Schematic for BCS-AM. The segmental excision
surgical specimen is removed using wire localization. Additional
margins can then be re-excised from each of the six faces of the
cavity (anterior, posterior, superior, inferior, medial, and lateral).
(b) BCS-AM surgical specimen. The total tissue obtained from the
BCS-AM procedure includes the original localized lesion (shown
with wire placement), as well as one or more additional margins
from the six surfaces.
dissection are both used to excise the lesion. The margins are
marked accordingly with a long suture denoting the lateral
margin and a short suture denoting the superior margin. A
conﬁrmatory digital specimen X-ray is taken in 2 views and
the ﬁlms are reviewed intraoperatively by the surgeon. The
specimen is then sent to pathology as a fresh specimen. The
breast imager subsequently reviews the specimen ﬁlm.
At the discretion of the surgeon, additional margins are
taken. They are oriented using a suture to mark the new true
margin and secured to a telfa pad and sent to pathology as a
fresh specimen.
2.2.2. Surgeon B. For palpable lesions, excisions are per-
formed with estimated margins of at least 1cm and suture
tagged for orientation. When any margin is measured in theInternational Journal of Surgical Oncology 3
Table 1
(a) Comparison of patients who underwent BCS, BCS-AM, and TM procedures.
BCS BCS-AM TM
No. of patients 201 151 53
Age (mean) 58 59 54
Age (median) 58 58 54
DCIS grade
Grade I 17 10 5
Grade II 88 53 15
Grade III 96 88 33
DCIS size
<1cm 67 44 9
1-2cm 37 22 6
2–5cm 27 19 9
>5cm 9 1 2
N/A 61 65 27
Necrosis
Yes 124 106 40
No 77 45 13
Calciﬁcations
Yes 147 109 37
No 53 42 16
Multifocality
Yes 112 101 34
No 89 50 19
ER
71–100% 112 83 19
41–70% 8 10 3
11–40% 5 2 0
0–10% 29 26 23
N/A 47 30 8
PR
71–100% 22 15 8
41–70% 15 13 5
11–40% 24 16 4
0–10% 93 76 28
N/A 47 31 8
ER/PR
Both 71–100 29 19 8
Both <10 19 25 19
Margin∗∗
Positive, <1mm 117 61∗ 1
1-2mm 23 9∗ 0
3–5mm 17 17 0
6–9mm 6 4 0
≥10mm 37 60∗ 52
Re-excision 129 61∗∗∗ 2
Residual DCIS 65 33∗ 0
BCS: breast conserving surgery; BCS-AM: BCS plus additional margin; TM: total mastectomy. ∗P <. 05, ∗∗P total <.0001, ∗∗∗P <. 0001.4 International Journal of Surgical Oncology
(b) Indications for surgery and re-excision, categorized by surgeon.
Surgeon A Surgeon B Surgeon C Surgeon D Total %
Indication for surgery
Palpable mass 5 10 4 5 24 6.8
Nonpalpable mass 14 0 0 0 14 4.0
Calciﬁcations 55 96 59 67 277 78.7
Mammographic lesion 53 15 59 70 197 56.0
Sonographic lesion 8 0 6 0 14 4.0
MRI lesion 6 11 7 1 25 7.1
Surgical procedure
Needle localization 60 85 40 67 252 71.6
Surgery bracket 10 2 4 0 16 4.5
Indication for re-excision
DCIS at margin 6 18 11 13 48 31.4
Clearance <1mm 22 28 13 16 79 51.6
Clearance <2mm 9 4 4 2 19 12.4
Clearance <3mm 5 1 1 0 7 4.6
pathology laboratory on immediate inspection as closer than
the desired 1cm, an additional segment is excised from the
excisionbedatthatsite.Superﬁciallesionsareusuallyexcised
with an ellipse of overlying skin. Posterior lesions are excised
down to and often including the underlying muscle fascia.
Nonpalpable lesions, including microcalciﬁcations and/or
biopsy clips, are excised with hook wire localization and
specimen radiographic control to insure complete excision.
The hook wire localizer provides additional orientation, and
any margins estimated as close on specimen radiography,
or by direct inspection for mass lesions or clips in the
pathologylaboratory,aretreatedbyadditionalexcisionofthe
appropriate cavity margin sites.
2.2.3. Surgeon C. For a palpable mass, the lesion is excised
with an approximate 1cm margin of normal tissue, then the
specimen is examined for adequacy of margins and oriented
with sutures. Additional margins are routinely excised, the
extent of which is inﬂuenced by the original specimen.
Superior, medial, inferior, lateral, anterior, and posterior
margins are excised, oriented with sutures to indicate new
margin, and sent individually fresh to pathology.
For radiologic-detected disease, following needle local-
ization of a mass lesion, calciﬁcations or a clip, an excision
is performed around the lesion and localizing guidewire.
If the lesion is superﬁcial, an ellipse of overlying skin is
removed; the pectoralis fascia is usually taken as the deep
margin. Then, additional margins are routinely excised and
sent to pathology, with the extent of excision based on
inspection of the specimen and the specimen radiograph.
If the radiologic abnormality is not included in the needle-
localization specimen, or only partially included, the surgical
site is ﬁrst re-excised and the new specimen X-rayed. If
this includes the lesion, routine margins are then sent as
above.
2.2.4. Surgeon D. Using a 10-blade scalpel, the segment
of breast tissue containing the lesion (palpable or area
localized by a hook wire) is excised with 1cm margins
of grossly uninvolved tissue and oriented with sutures. A
Babcock clamp and 10-blade scalpel are then used to obtain
additional margins of at least 1cm in the superior lateral,
inferior medial, anterior, and posterior planes. For lesions
subadjacent to the skin, a small ellipse of overlying skin
is included as an anterior margin. Deep lesions lying on
the pectoralis major fascia are excised en bloc with the
underlying fascia. A thin superﬁcial layer of underlying
muscle is obtained to augment the deep posterior surgical
margin. All true margins are marked with sutures.
2.3. Pathological Examination. The excision specimens were
measured in three dimensions and oriented, and six aspects
were inked with diﬀerent colored inks that can withstand
histological processing. The specimen was serially sectioned
along the long axis, and biopsy site and clip, if present, were
identiﬁed. All cases were submitted entirely for microscopic
examination. Additional margin specimens were measured
in three dimensions and oriented with one suture identifying
the true margin, which was typically inked black, with the
opposite margin inked blue. The additional margins were
also submitted entirely for microscopic examination.
Volume of each specimen was calculated by multiplying
the three dimensions of each specimen, noted on gross
examination.TheextentofDCISwasreportedasthenumber
of slides with DCIS and total number of slides for the case.
If DCIS was present >10mm from a margin, it was
considered negative and this distance was not reported in
the ﬁnal pathology report. If DCIS was <10mm from a
margin, the closest distance to the margin was reported.
Microscopic examination of DCIS included assessment of
morphologic subtype, nuclear grade, necrosis, multifocality,International Journal of Surgical Oncology 5
and calciﬁcations. Multifocality is deﬁned as presence of
DCIS in a section prepared from more than one block of the
specimen, which is the standard deﬁnition used by NSABP
[1]. The volume of DCIS was assessed on microscopic
examination as number of slides with DCIS over the total
number of slides. Immunohistochemical stains for estrogen
receptor (ER) (SP1 antibody, Ventana) and progesterone
receptor status (PR) (1E2, Ventana) were performed for all
cases and reported as a percentage. Microscopic examination
of re-excisions used the same parameters as for primary
excision. The ﬁnal pathology report included a summary
of pathological variables, including the margin status and
biomarkers (ER and PR).
3. Results
3.1. Re-Excision Rate for BCS-AM Is Signiﬁcantly Lower than
for BCS. Patients who underwent BCS (n = 201), BCS-
AM (n = 151), or TM (n = 53) for DCIS between 2004
and 2008 at NYUMC were compared by clinicopathological
variables and were found to be similar in age, grade and size
of DCIS, necrosis, multifocality, calciﬁcations, and ER/PR
status(Table 1(a)).PatientswhounderwentBCS-AMinstead
of BCS had a 10% lower incidence of positive or <1mm
margins (P<. 05) and a 24% higher incidence of widely
negative margins (>10mm; P<. 05). Accordingly, rates for
re-excision were signiﬁcantly (P<. 0001) lower in the BCS-
AM cohort compared to the BCS alone (BCS-AM: 40%,
BCS: 64%). Residual DCIS in re-excision specimens was also
signiﬁcantly lower (P<. 05) when AM was obtained (BCS-
AM: 22%, BCS: 32%). Residual DCIS was found in roughly
half of the re-excisions for the BCS group (50%) compared
tothe BCS-AM group (54%),whichis statisticallysigniﬁcant
(P<005).
3.2. Pathological Predictors for Re-Excision. Seven variables
(necrosis, multifocality, calciﬁcation, ER, PR, total volume,
BCS, or BCS-AM) and their cross-products with BCS/BCS-
AM (six more variables) were analyzed to see which could be
used to predict the response variable, the probability that re-
excision surgery will need to be performed (Table 2(a)). The
optimal model (P ≤ .0001) for this response variable was
found by comparing a series of reduced multivariate logis-
tical regressions using G2 test statistics and log likelihoods.
After completing this analysis, the optimal model to predict
the probability of the occurrence of a re-excision surgery
contained four signiﬁcant predictors: BCS/BCS-AM (P ≤
.0001), multifocality (P = .0002), total volume (P = .0284),
andER(P = .0382)(theseP valuescomefromtheparameter
estimates in the optimal reduced model) (Table 2(b)). The
variables necrosis (P = .5300), calciﬁcation (P = .8007), and
PR (P = .9952) were found to be insigniﬁcant predictors
and were, therefore, not in the optimal model (these P
values come from the parameter estimates in the original full
model).
3.3. Higher Excision Volume Is Related to Lower Rate of
Re-Excision. For both the BCS and the BCS-AM cohorts,
volume of tissue excised is inversely correlated to the rate
of re-excision (Table 3). In the BCS group, patients with
and without re-excision had total volumes of 77.8cm3 and
100.3cm3,r e s p e c t i v e l y ,( P = .067). Patients who underwent
BCS-AM with and without re-excision had total volumes
of 98.7cm3 and 127.2cm3,r e s p e c t i v e l y ,( P = .281). The
volume of additional margins with and without re-excision
was 28.9cm3 and 26.3cm3,r e s p e c t i v e l y( P = .44). The
volume of excision for all patients who did not undergo re-
excision was 114.96cm3 and those who did was 79.6cm3.
Using a two sample t-test, a signiﬁcant diﬀerence in total
volume was found when comparing BCS and BCS-AM
surgery (P = .0003). Furthermore, when comparing surgery
type with respect to re-excision rates using a series of
two-sample t-tests, a signiﬁcant diﬀerence in volume size
was found between BCS surgery that required re-excision
surgeryandBCS-AMthatdidnotrequirere-excisionsurgery
(P ≤ .0001). A subset analysis of patients with positive or
close margins (<1mm) only found the volume of excision
specimen not statistically signiﬁcant (P = .713).
The patients were stratiﬁed by margin status, regardless
of the procedure performed, to examine the relationship
between negative margins and total volume (Table 4). The
ﬁve margin size categories’ total volumes were compared
usingaseriesoftwo-samplet-tests.Asigniﬁcantdiﬀerencein
totalvolumewasobservedwhencomparingpositivemargins
with all the other margin sizes. In this analysis, widely
negative margins (>10mm) correlated with the highest
average total excision volume (130.4cm3)a n dp o s i t i v e
margin status correlated with the lowest (61.2cm3)a v e r a g e
total excision volume. Width of margin, represented by ﬁve
diﬀerent groupings (positive, 1-2mm, 3–5mm, 6–9mm,
negative), and total excisional volume were linearly related
(r2 = 0.931).
3.4. Surgeon (Surgical Technique) As a Variable for Rate
of Re-Excision. Individual surgeons were also compared to
determine if variation in surgical techniques (BCS and BCS-
AM) was a signiﬁcant variable for rate of re-excision. Four
surgeons performed 86.6% of the surgical procedures. Nine
surgeons did not perform a minimum of 30 surgeries, have
a minimum cell size of 5 for BCS and BCS-AM surgeries,
or perform a minimum of 10% of the surgeries in the total
sample. To keep the statistical power of the ANOVA and the
chi-squared test high (1-β>0.8), only the ﬁrst four surgeons
were compared.
The surgeons’ techniques were compared by individual
re-excision surgery rates relative to three major variables:
type of surgery (BCS/BCS-AM), total volume, and margin
size. The rate of re-excision surgery after BCS (P = .141355)
and BCS-AM (P = .186487) was compared using the
chi-squared test and no signiﬁcant diﬀerence was demon-
strated among the surgeons (Table 5(a)). For specimens
that required a re-excision, the specimen volumes for each
surgeonwerecomparedusingaone-wayAnalysisofVariance
test,andnosigniﬁcantdiﬀerencewasfoundbetweenthesur-
geons (P value of F statistics =.156) (Table 5(b)). Individual
surgeon’srateofre-excisionsurgerywascomparedbymargin6 International Journal of Surgical Oncology
Table 2
(a) Comparison of patients who did not require re-excision to those who underwent re-excision.
BCS BCS-AM TM
Re-excision No Yes No Yes No Yes
No. of patients 72 129 90 61 51 2
Re-excision No Yes No Yes No Yes
No. of patients 72 129 90 61 51 2
Necrosis
Y e s 3 98 26 2 4 4 3 72
No 33 45 28 17 13 0
N / A 0 2 000 0
Calciﬁcations
Y e s 5 19 56 7 4 1 3 62
No 21 30 23 19 15 0
N / A 0 4 000 0
Multifocality
Y e s 3 67 45 3 4 8 3 41
No 36 50 37 13 17 1
N / A 0 4 000 0
ER
71–100% 40 72 50 34 21 0
41–70% 2 6 7 3 2 0
11–40% 3 2 1 1 3 0
0–10% 7 20 11 14 16 2
N / A 2 02 22 1 9 9 0
PR
71–100% 8 13 10 5 7 0
41–70% 7 8 6 7 5 0
11–40% 2 22 8 8 5 0
0–10% 35 57 44 32 25 2
N / A 2 02 22 2 9 9 0
ER/PR
Both 71–100% 8 16 10 8 8 0
Both 0–10% 7 16 11 14 15 2
(b) Statistical signiﬁcance of predictors for re-excision.
Parameter Prob > Chi Sq
BCS ∗ <.0001
Multifocal ∗.0002
Total volume ∗.0284
ER ∗.0382
Necrosis .5300
PR .9952
Calciﬁcations .8007
∗Signiﬁcant predictor of re-excision. The P values of the chi-squared test show the signiﬁcance of each parameter as a predictor of the response variable, rate
of re-excision surgery. If the P value is less than .05, then the parameter is considered signiﬁcant and is a good predictor in the model for re-excision.International Journal of Surgical Oncology 7
Table 3
(a) Comparison of the average total volume of BCS and BCS-AM surgery relative to re-excision surgery.
Re-excision
No Yes P Total
BCS 100.3 (n=79) 77.8 (n=122) ∗.067 86.6 (n=201)
BCS-AM 127.2 (n=95) 98.7 (n=56) ∗.281 116.6 (n=151)
Total 114.9 (n=174) 79.6 (n=178) ∗.003
∗∗ <0.001
AM alone 26.3 (n=95) 28.9 (n=56) ∗.444 24.6 (n=151)
BCS-AM: all resected tissue, including additional margins. AM alone: volumes of additional margins taken with BCS for BCS-AM samples. The volumes of
each category were compared relative to re-excision surgery using the P values from two-sample t-tests with unequal variances. ∗P value reﬂects diﬀerence
between “yes” and “no” for each listed group. ∗∗P value reﬂects diﬀerence between “total BCS” and “total BCS-AM”.
(b) Comparisonofaveragetotalvolume(cm3)forBCSandBCS-AMsurgeryrelativetore-excisionsurgeryusingdataonlyfromthepositiveandclosemargin
(<1m m)c o h o r t .
Re-excision
No Yes P Total
BCS 81.5 (n = 19) 72.9 (n = 98) .773 74.3 (n = 117)
BCS-AM 97.6 (n = 17) 100.961 (n = 44) .907 100.0 (n = 61)
Total 89.0 (n = 36) 81.6 (n = 142) .713∗ 83.1 (n = 178)
∗∗ < 0.079
∗P value reﬂects diﬀerence between “yes” and “no” for each listed group. ∗∗P value reﬂects diﬀerence between “total BCS” and “total BCS-AM”.
Table 4: Volume of excision relative to the margin status.
Margins (n=351) Total avg volume (cm3)
Positive (n = 178) 83.1
1-2mm (n = 32) 79.4
3–5mm (n = 34) 113.5
6–9mm (n = 10) 112.9
Negative (n = 97) 130.4
F statistic = 3.48 P value = .008
∗
This table compares the total average volume of each of the ﬁve categories
using P values of two-sample t tests with unequal variances, after the data
experienced a natural log transformation. ∗P value represents P value of F
statistic in ANOVA test.
size (Table 5(c)). Each surgeon was compared to the three
other surgeons using chi-squared tests or F statistics from an
ANOVA, and no signiﬁcant diﬀerence was found.
4. Discussion
In this study, we evaluated the eﬃcacy of simultaneous
additional margin excision at the time of initial BCS in
reducing the rate of surgical re-excision. Our data show that
BCS-AM, compared to BCS, had a 10% lower incidence of
positive or <1mm margins (P<. 05) and a 24% higher
incidence of widely negative margins (>10mm; P<. 05).
Accordingly, rates for re-excision were signiﬁcantly
(P<. 0001) lower in the BCS-AM cohort than the BCS alone
(BCS-AM: 40%, BCS: 64%). Statistical analysis revealed
multifocality (P = .0002), total volume (P = .0284), and
ER (P = .0382) to be signiﬁcant predictors of re-excision
in our population. In this study, total excision volume
correlated with margin width regardless of procedure and
variation in surgical technique and was inversely correlated
with re-excision rate for both BCS and BCS-AM. In cases of
re-excision, the total volume of tissue excised with BCS-AM
is higher than that with BCS, and the dataset is limited in
this regard. Variation in surgical technique was not found
to be a signiﬁcant variable. As such, our analyses emphasize
the importance of total excision volume in successful BCS
procedures and validate BCS-AM as an eﬀective means of
retaining anatomical accuracy and reducing the incidence
of a second re-excision procedure. The major concern in
the management of patients in our setting was the need
for subsequent excision where margin widths were neither
widelynegative(>10mm) nor deﬁnitively positive (<1mm).
The decision to re-excise in these cases was the presence
of DCIS in the vicinity of the margin for all four surgeons
and was performed without exception for margins <1mm.
Despite a generally uniform approach to the BCS and BCS-
AM technique at our institution, we recognize that surgeon
variability is a potential confounder in our study. To address
this, we compared the four major surgeons involved in our
case cohort (representing 87% of cases) and found they
were not statistically diﬀerent with respect to our outcome
measures.
Taking additional margins provides a technical beneﬁt to
the pathologist. Additional margins provide more accurate
spatial orientation of the surgical specimen compared to8 International Journal of Surgical Oncology
Table 5
(a) The rate of re-excision for each surgeon compared to type of surgery (BCS/BCS-AM).
Surgeon∗ BCS BCS-AM
# Re-exc Total Percent # Re-exc Total Percent
A 24 35 68.57% 17 31 54.84%
B 18 37 48.65% 11 39 28.21%
C 41 78 52.56% 9 20 45.00%
D 20 22 90.91% 12 43 27.91%
Summary chi squared P value chi squared P Value
Total 5.455184 0.141355∗∗ 4.807951 0.186487∗∗
∗Only top four surgeons were chose to keep power of the test above 0.80.
(b) The rate of re-excision for each surgeon compared by average total volume of excision (cm3).
Surgeon∗ AB C D
Volume 80.94 97.06 102.88 57.40
St Dev 72.45 86.98 124.09 51.14
N 41 29 50 32
F statistic. 1.77 P value 0.156
∗Only top four surgeons were chose to keep power of the test above 0.80.
(c) The rate of re-excision for each surgeon compared relative to margin size.
Margin size Surgeon A Surgeon B Surgeon C Surgeon D Total
Re-exc n Re-exc n Re-exc n Re-exc n Re-exc nP value
Pos 25 32 25 35 42 48 29 33 121 148 .836699
1-2mm 9 10 3 7 2 5 2 5 16 27 .468393
3–5mm 6 9 0 7 2 8 1 2 9 26 .141999
6–9mm 0 5 1 4 0 1 0 0 1 10 .472367
Neg 1 10 0 23 4 34 0 24 5 91 .145699
Total 40 56 29 53 46 62 32 40 147 211
inking by a pathologist, as the in situ anatomy is at variance
fromtheexcisionspecimen.Therearealsoinstancesinwhich
inked specimen margins provide false negative data that an
additional margin would in eﬀect correct. A recent study
by Povoski et al. found that half of their additional margin
specimens that were positive for carcinoma (13/24) had a
negative excision specimen [13]. We also, however, noted
the reverse eﬀect in our study, as did Cao et al. [11], in
which a re-excision performed for a positive margin was
negative in a number of cases. Some possible explanations
for this include small residual tumor volume, tissue necrosis
at the new margin, or tissue friability as a result of
processing. Interestingly, Rizzo et al. did not ﬁnd additional
margin sampling to be signiﬁcantly burdensome or costly
to pathologists [14]. Additional margins should represent
entire aspects of the excision cavity; however, currently, there
is no reproducible and eﬀective method to ascertain spatial
accuracy of additional margins.
This analysis has some limitations inherent in a retro-
spective cohort. The inclusion criteria (indication for sur-
gery, e.g., palpable mass, non-palpable mass, calciﬁcations,
mammographic, sonographic, or MRI lesion) were not
controlled for. The endpoint of this study is the rate of
re-excision. In addition, our study does not provide long-
term followup and outcome; thus, we cannot comment on
how BCS and BCS-AM compare with respect to disease-free
survival.
Shaving additional margins for excision of invasive
and noninvasive carcinoma has already been shown to be
eﬀective in reducing re-excision rates and reducing margin
positivity for early stage breast cancer [9, 11–15] Cao and
colleagues [11] retrospectively examined 126 patients with
either DCIS (n = 23) or IDC (n = 103), all of whom
underwent BCS-AM surgery that was similar in methodol-
ogy to our series (Figure 1). Among their patients, 103 had
excisional specimens with histologically positive margins;
yet, of these patients, only 52 (50.5%) had detectable carci-
noma present on the additional margins. The investigators
identiﬁed two pathological features, namely, “large tumor
size” and “presence of a DCIS component” as signiﬁcantly
correlated with histologically positive lumpectomy margins
(in which carcinoma is <2mm from surface). By examiningInternational Journal of Surgical Oncology 9
the pathology from both the original lumpectomy margins
and the additional margins, they determined that 59% of
margins were histologically negative as a direct result of
removing additional margins.
As t u d yb yJ a n e sa n dc o ll e a g u e s[ 9] found similar eﬃcacy
in the surgical approach, linking systemic superior and in-
ferior cavity shavings (SSICS) to reduction in close margins
and re-excision rates. SSICS is a technique identical in
principle to the “additional margins” approach employed
in our study. The investigators prospectively compared two
groups of patients. The ﬁrst (n = 106) was a group with
IDC or DCIS who underwent BCS, followed by pathological
examination of the specimen. If margins were deemed
<10mm, then additional margins were removed as needed.
In the second group, patients underwent SSICS initially. The
group receiving SSICS had a reduced rate of close margin
(18/106 versus 8/111 or 17% versus 7%) and a reduced rate
of re-excision.
Several other retrospective analyses are notable as well.
In a separate retrospective study, Huston et al. [15]d i v i d e d
a group of 171 patients with IDC/DCIS into three subdivi-
sions, based on number of additional margins obtained (4–
6, 1–3, and 0), and compared their respective rates of re-
excision.Re-excisionwasperformedifanymarginwasfound
to contain carcinoma within 2mm of its border edge. They
foundthatthegroupwith4–6marginshadareoperativerate
of 17.7% compared with 32.5% and 38.7% for the other two,
respectively. Interestingly, the three groups also had diﬀerent
volumes, correlating with the reoperative rates, as was the
case in our data (129.19cm3, 46.04cm3, and 37.44cm3,
resp.) In another analysis of 125 DCIS and IDC lumpectomy
specimens, Jacobson et al. report that by taking additional
margins re-excision was avoided in 49% of their patients for
whom it otherwise would have been necessary [12]. Rizzo
and colleagues reported 320 patients who underwent BCS
(n = 199) or BCS-AM (n = 121) for either DCIS or
IDC and observed an increase in negative margins (85.1%
from 57.2%) and a decrease in re-excisions with additional
margins. This study did not ﬁnd the eﬀect to be signiﬁcant
for DCIS when it was analyzed separately [14].
As discussed above, prior reports suggest that excising
additional margins reduces both positive margin status and
rateofre-excisionforIDCandIDCwithaDCIScomponent.
Our data suggest that this eﬀect is also true for cases of pure
DCIS and that the approach is successful because of higher
overall excision volumes. The importance of this ﬁnding is
highlighted by the published literature linking volume of
excision to rates of recurrence. A report by Vicini et al.
reviewed 146 patients who received BCS for DCIS and used
a multivariate analysis to identify factors associated with
reduced local recurrence. They concluded that margin width
and volume were both independent predictors of outcome
[16]. Similarly, Hwang et al. found that elderly patients with
DCIS seen at their institution were more likely to have large
volume excisions as compared to younger patients. They
propose this as one possible reason forlower recurrence rates
in the elderly group [17] .S u r g e o n sm a yb em o r er e l u c t a n tt o
excise larger volumes of tissue in younger patients with DCIS
because of potential cosmetic deformity.
5. Conclusion
Our studies found multifocality to be strongly associated
with re-excision in agreement with the National Surgical
Adjuvant Breast and Bowel Project (NSABP B-17), in which
multifocality was predictive of positive margins [1]. DCIS
is generally not a palpable lesion, making multiple foci
more challenging to identify during surgery, even with
wire-guided radiological assistance. These multiple foci may
represent an artifact of pathological processing, where a
three-dimensional disease process is visualized in a two-
dimensional format. Multiple foci of DCIS in the same
quadrant probably represent the same genetic proﬁle, as has
been demonstrated for invasive carcinoma [18]. Our data
suggest that excising additional margins for DCIS increases
thetotalaverageexcisionvolumeanddecreasestheincidence
of re-excision.
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